ICUI Stock Recent News
ICUI LATEST HEADLINES
NEW YORK , May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU" or the "Company") (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK CITY, NY / ACCESS Newswire / May 6, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI.
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK CITY, NY / ACCESS Newswire / May 5, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI.
NEW YORK CITY, NY / ACCESS Newswire / May 4, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI.
NEW YORK, NY / ACCESS Newswire / May 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc.("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI.
NEW YORK CITY, NY / ACCESS Newswire / May 1, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI.
The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market. SAN CLEMENTE, Calif.